Maximum quantity allowed is 999
Please select the quantity
CAS RN: 146939-27-7 | Product Number: Z0034
Ziprasidone
Purity: >98.0%(HPLC)
Synonyms:
Product Documents:
Size | Unit Price | Shanghai | Tianjin | Japan* |
---|---|---|---|---|
100MG |
¥360.00
|
3 | 6 | 3 |
1G |
¥2,550.00
|
Contact Us | 1 | 1 |
* For order or inquiry, please contact
Our Authorized Distributors.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
* To send your quote request for bulk quantities, please click on the "Request Bulk Quote" button. Please note that we cannot offer bulk quantities for some products.
Product Number | Z0034 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__1H__2__1ClN__4OS = 412.94 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image), 1G-Glass Bottle with Plastic Insert (View image) |
CAS RN | 146939-27-7 |
Reaxys Registry Number | 6669199 |
PubChem Substance ID | 253660462 |
Merck Index (14) | 10171 |
MDL Number | MFCD00866661 |
Specifications
Appearance | Light yellow to Brown powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 95.0 % |
Melting point | 218.0 to 224.0 °C |
Properties (reference)
Melting Point | 222 °C |
Solubility in water | Insoluble |
Degree of solubility in water | 2.1 mg/l 25 °C |
GHS
Pictogram | |
Signal Word | Warning |
Hazard Statements | H336 : May cause drowsiness or dizziness. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P271 : Use only outdoors or in a well-ventilated area. P304 + P340 + P312 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell. P403 + P233 : Store in a well-ventilated place. Keep container tightly closed. P405 : Store locked up. |
Related Laws:
RTECS# | NM3241000 |
Transport Information:
Customs Control Conditions (Q) |
Application
Ziprasidone: A Unique Combined 5-HT and Dopamine Receptor Antagonist
Ziprasidone is a combined 5-HT (serotonin, [S0370 (Hydrochloride)]) and dopamine [A0305 (Hydrochloride)] receptor antagonist. The mechanism of action of ziprasidone, as with other drugs having efficacy in schizophrenia, is unknown. However, it has been reported that has high affinity for serotonin 5-HT2A and dopamine D2 receptors in vitro.
References
- Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity
- 5-HT1A receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex
- Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile
- Ziprasidone: the fifth atypical antipsychotic (a review)
- Ziprasidone Metabolism, Aldehyde Oxidase, and Clinical Implications
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.